NeuPath Health price target cut by Stifel to C$0.58
Stifel cut its price target for NeuPath Health Inc. to C$0.58 from C$0.68 while maintaining a Strong Buy rating, per Baystreet.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.